Sage Journals: Discover world-class research

Free access

Review article

First published 2015-12

Recent advances in the development of Aurora kinases inhibitors in hematological malignancies

Iqra Choudary, Paul M. Barr, Jonathan Friedberg

Therapeutic Advances in Hematology

Free access

Research article

First published 2013-2

Development of a Fluorescence Intensity Assay for the Mitotic Serine/Threonine Protein Kinase Aurora-A

Andrew F. Slatter, Spencer Campbell, Richard M. Angell

Journal of Biomolecular Screening

Free access

Research article

First published 2010-9

Functional Analysis and Molecular Targeting of Aurora Kinases A and B in Advanced Melanoma

Xiaolei Wang, Stergios J. Moschos, Dorothea Becker

Genes & Cancer

Retricted access

Research article

First published 2019-10

Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735,an Aurora Kinase Inhibitor

Sevim Dalva-Aydemir, Cemaliye Boylu Akyerli, Şirin Kılıçturgay Yüksel [...]

OMICS: A Journal of Integrative Biology

Open access

Research article

First published 2024

In Silico Study,Protein Kinase Inhibition and Molecular Docking Study of Benzimidazole Derivatives

Kamaraj Karthick, Kamaraj Abishek, Ebenezer Angel Jemima

Bioinformatics and Biology Insights

Retricted access

Research article

First published 2026-3

AURKA Activates FOXO3a to Form a Positive Feedback Loop in the Proliferation and Migration of Keloid Fibroblasts

Xi Chu, Jiaqi Sun, Siya Dai [...]

Advances in Wound Care

Retricted access

Research article

First published 2023-10

Combination BRAF V600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAF V600E -Mutant Anaplastic Thyroid Cancer

Viswanath Gunda, Chandrayee Ghosh, Jiangnan Hu [...]

Thyroid®

Search results

Recent advances in the development of Aurora kinases inhibitors in hematological malignancies

Development of a Fluorescence Intensity Assay for the Mitotic Serine/Threonine Protein Kinase Aurora-A

Functional Analysis and Molecular Targeting of Aurora Kinases A and B in Advanced Melanoma

Toward In Vitro Epigenetic Drug Design for Thyroid Cancer: The Promise of PF-03814735,an Aurora Kinase Inhibitor

In Silico Study,Protein Kinase Inhibition and Molecular Docking Study of Benzimidazole Derivatives

AURKA Activates FOXO3a to Form a Positive Feedback Loop in the Proliferation and Migration of Keloid Fibroblasts

Combination BRAF V600E Inhibition with the Multitargeting Tyrosine Kinase Inhibitor Axitinib Shows Additive Anticancer Activity in BRAF V600E -Mutant Anaplastic Thyroid Cancer